📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation. (2021)

First Author: Bentley R

Attributed to: Maximising patient benefit: Leeds’ Interdisciplinary approach to translation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/13543784.2021.1897786

PubMed Identifier: 33682570

Publication URI: http://europepmc.org/abstract/MED/33682570

Type: Journal Article/Review

Volume: 30

Parent Publication: Expert opinion on investigational drugs

Issue: 10

ISSN: 1354-3784